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Fabry disease; glycosphingolipids; renal failure; myograph; reactive nitrogen species FABRY DISEASE is an X-linked glycosphingolipid disorder caused by deficiency or absence of activity of the lysosomal enzyme ␣-galactosidase A (Gla) (3, 12) . The loss of Gla leads to the progressive accumulation of neutral glycosphingolipids with terminal Gal-␣1-4Gal linkages, including globotriaosylceramide (Gb3), galabiosylceramide, and globotriaosylsphingosine. A primary site of glycosphingolipid accumulation is the vascular endothelium, although glycosphingolipid accumulation occurs in various other organ systems throughout the body (6, 23) . Premature life-threatening complications arise from involvement of the brain, heart, and kidneys and include cerebrovascular accidents, myocardial infarction, and progressive renal insufficiency (7) . Affected hemizygous males and female carriers suffer from Fabry disease-related complications (14, 25) .
The vascular complications of Gla deficiency have been the primary focus of clinical and mechanistic studies of this rare disease. However, the earliest and most common symptoms of Fabry disease are gastrointestinal and include abdominal pain, constipation, diarrhea, and nausea (7, 20) . Because these symptoms are common, the diagnosis of Fabry disease is often delayed (20) .
Clinical and experimental studies have focused on the hypothesis that endothelial dysfunction may underlie the macrovascular and microvascular complications associated with Fabry disease. The Gla-knockout mouse can be used to characterize and study inducible models of vasculopathy. Robust vascular phenotypes, including accelerated atherogenesis and thrombus formation following photochemical injury, have been reported in these mice (2, 5) . In isolated aortic rings, Gb3 accumulation in the endothelium is linked to a defect in endothelial nitric oxide (NO)-mediated vasodilation (17) . These and other findings are consistent with a Gb3-dependent loss of NO bioavailability as a common mechanism linking atherogenesis, thrombosis, and impaired vasorelaxation.
The purpose of this study was to determine whether the vascular phenotype in the Gla-knockout mouse extends beyond the aorta and carotid vasculature. Specifically, an age-dependent mesenteric artery (MA) phenotype was characterized in Gla-deficient mice. Age-dependent Gb3 accumulation, in conjunction with a profound loss of microvascular reactivity and increased endothelial NO synthase (eNOS) uncoupling, was observed in MAs of Gla-deficient mice.
METHODS

Mice.
A breeding colony of Gla-null mice was established from mice provided by Ashok Kulkarni (National Institutes of Health). The knockout mice (129/SvJXC57BL/6) were originally generated by replacement of the Gla gene with a neomycin resistance (neo) sequence within a portion of the exon 3 and intron 4 region (16). These mice were backcrossed a minimum of six generations to the C57BL6/J strain. The Gla-null and wild-type (WT) C57BL/6 mice were maintained in the University of Michigan animal facility under standard conditions. All animal experiments were performed according to a protocol approved by the University of Michigan Committee on the Use and Care of Laboratory Animals.
Vascular reactivity experiments. Two-to 9-mo-old mice were euthanized with an injection of pentobarbital sodium (66.5 mg/kg ip). A segment of small intestine was removed and placed in a dissection petri dish filled with cold physiological salt solution (mmol/l: 130 NaCl, 4.7 KCl, 1.18 KHPO4, 1.17 MgSO4, 1.6 CaCl2, 14.9 NaHCO3, 5.5 dextrose, and 0.03 CaNa2 EDTA). Second-order MAs (2-3 mm long) were carefully dissected, and connective tissue surrounding the arteries was removed. The individual vessel segment was mounted on glass cannulas in a pressure-myograph system (model 110P, Danish Myo Technology, Aarhus, Denmark). Vessel diameter was monitored and analyzed digitally in real time (DMT Vessel Acquisition Suite 6.2, Danish Myo Technology). In studies to determine ACh-mediated relaxation without endothelium, the endothelium was denuded during the mounting procedure by exposure of endothelial cells to an air bubble for 30 s. Mounted MAs were bathed with warmed (37°C) and aerated (95% O 2-5% CO2) physiological salt solution. MAs were pressurized at 20 mmHg, and the pressure was increased 10 mmHg every 5 min until it reached 60 mmHg. The vessels were then equilibrated for 60 min. Prior to ACh-and sodium nitroprusside (SNP)-mediated vascular reactivity studies, the vessels were subjected to osmotically balanced high-potassium physiological salt solution (mmol/l: 14. Tissue lipid extraction and Gb3 analysis. Frozen MA tissues, dissected from 1-to 12-mo-old WT and Gla-null mice, were thawed in 0.8 ml of ice-cold sucrose buffer (250 mM sucrose, pH 7.4, 10 mM HEPES, and 1 mM EDTA) per sample and homogenized with a TRI-R homogenizer at 10% output. Total and neutral lipid extraction, separation by high-performance thin-layer chromatography, and quantification were performed as previously described (23) .
Western blotting. For immunoblot analysis, frozen MA tissues were thawed in ice-cold lysate buffer formulated with 25 mM Tris·HCl (pH 7.4), 137 mM NaCl, 2 mM EDTA, 2 mM Na3VO4, 20 mM NaF, 1% Triton X-100, 10% glycerol, and a 1ϫ mixture of the phosphatase/protease inhibitors P2714, P0044, and P5726. Unfrozen samples were homogenized with a TRI-R homogenizer for 20 s at 5% output at 4°C and then sonicated five times with a probe sonicator for 1 s at 50% output at 4°C. The cell debris was removed by centrifugation at 10,000 g for 10 min at 4°C.
Total protein in each MA sample was quantified by bicinchoninic acid assay, with bovine serum albumin used as a standard. To determine total eNOS expression in MAs of WT and Gla-null mice, 40 g of MA lysate protein, either denatured with 1% 2-mercaptoethanol or nondenatured, were separated by SDS-PAGE using a 6 -12% gradient. Monomeric and homodimeric eNOS in MAs from WT and Gla-null mice was detected with a mouse anti-human eNOS monoclonal antibody at a concentration of 0.5 g/ml. MA samples for determination of protein-bound 3-nitrotyrosine levels were dissected from WT and Fabry mice in antioxidant buffer containing 100 M diethylenetetraamine pentaacetic acid, 50 M butylated hydroxytoluene, and 10 l/ml protease inhibitor (Pierce, Rockford, IL). Expression of 3-nitrotyrosine in MA samples was evaluated using a mouse anti-human 3-nitrotyrosine antibody (0.4 g/ml) diluted in blotting buffer (Tris-buffered saline) consisting of 20 mM Tris·HCl (pH 7.6), 150 mM NaCl, and 2.5% fat-free dry milk. Primary antibodies against human phosphorylated (Thr 495 ) eNOS (0.5 g/ml) and bovine phosphorylated (Ser 1179 ) eNOS (1.0 g/ml) residues were selected to measure phosphorylation of eNOS in MAs from WT and Gla-null mice. Both antibodies were diluted in 1% milk-Tris-buffered saline.
On the basis of amino acid sequence homology, all the eNOS-specific antibodies cross-react with indicated proteins in mouse MAs. The immunoreactive bands were stained with the ECL Plus system and quantified by densitometric scanning using ImageJ software. Statistical analysis. GraphPad Prism software was used for statistical analysis. Values are means Ϯ SE. Results were analyzed using unpaired t-test for comparison of two groups. For multiple comparisons, data were analyzed using two-way ANOVA followed by Bonferroni's post hoc analysis. Statistical significance was set at P Ͻ 0.05.
RESULTS
Age-dependent Gb3 accumulation in MAs from
Gla-null mice. MAs from 2-and 9-mo-old WT mice on a C57BL/6 background had no detectable Gb3. However, in MAs from Gla-deficient mice, Gb3 levels were readily detected at 2 mo and markedly elevated at 9 mo of age (Fig. 1A) . Gb3 levels were fivefold higher in MAs from 9-mo-old Gla-knockout than 2-mo-old Gla-knockout mice (Fig. 1B ) and continued to increase through 12 mo of age (Fig. 1C) . These data indicate that Gb3 accumulation in MAs from Gla-null mice is progressive as a function of age.
ACh-mediated relaxation in endothelium-intact MAs. Endothelium-dependent relaxation to ACh was examined in isolated MAs from WT and Gla-null mice that were precontracted with NE (10 Ϫ5 M). MAs from 2 mo-old Gla-knockout mice dilated significantly less (15.9 Ϯ 5.8%, P Ͻ 0.001) than MAs from age-matched WT mice (53.4 Ϯ 9.2%) in response to the highest dose of ACh (10 Ϫ4 M; Fig. 2A ). MAs from 8 mo-old WT mice relaxed in a concentration-dependent manner following exposure to ACh. Relaxation to the highest concentration of ACh in MAs from 8-mo-old WT mice (59.2 Ϯ 5.6%) was comparable to that in MAs from WT 2-mo-old mice. By contrast, MAs from age-matched Gla-null mice were nearly devoid of ACh-mediated dilation (1.5 Ϯ 5.8%, P Ͻ 0.001; Fig.  2B ).
SNP-mediated relaxation in endothelium-intact MAs. The difference in ACh-dependent relaxation could be secondary to a functional defect in the endothelium or smooth muscle cells. To determine whether the responsiveness of the smooth muscle layer to NO is different between MAs from WT and Gla-null mice, SNP, a NO donor, was added at increasing concentrations. SNP induced an endothelium-independent vasodilation in MAs from WT and Gla-knockout mice. At 2 mo of age, the maximum relaxation to SNP in MAs from WT mice (78.2 Ϯ 2.2%) was not statistically different from that in MAs from Gla-null mice (84.2 Ϯ 5.4%; Fig. 3A) . The maximum relaxation in MAs at 8 mo of age was also not different between WT (80.5 Ϯ 5.0%) and Gla-null (69.6 Ϯ 4.3%) mice. However, the SNP responsiveness in vessels from the 8-mo-old mice revealed a greater sensitivity at lower concentrations of SNP (10 Ϫ7 -10 Ϫ6 M) in WT than Gla-null mice (Fig. 3B) . ACh-and SNP-mediated dilation in endothelium-denuded MAs. It was next determined whether the attenuation of AChmediated relaxation in the Gla-null mice was endotheliumdependent. The endothelium of the MAs was removed before determination of the ACh and SNP dose responses. As expected, denuding of the MA endothelium inhibited any measurable vasodilation in response to ACh in vessels from WT or Gla-deficient mice (Fig. 4A) . SNP induced a concentrationdependent vasodilation in both groups, and the maximum relaxation did not differ between WT (75.9 Ϯ 3.2%) and Gla-null (74.4 Ϯ 5.7%) mice (Fig. 4B) .
Decreased eNOS homodimers and monomers in MAs from Gla-null mice. Next, the basis for the decrease in NO bioavailability was evaluated. Dimerization of eNOS is required for catalytic activity and NO production (27) . Two forms of eNOS, monomers and homodimers, can be measured by PAGE under reducing or nonreducing conditions. A decrease in eNOS dimers and monomers was observed at 8 mo of age in MAs from Gla-null mice compared with WT mice (Fig. 5A) . This difference was confirmed with repeated measurements (Fig.  5B) . The 53% decrease in homodimer expression in MAs from was not observed in MA extracts from 2-mo-old WT or Gla-null mice. However, eNOS phosphorylation at Ser 1179 was readily observed in MAs from 8-mo-old WT and Gla-knockout mice (Fig. 6A) . A modest decrement in eNOS phosphorylation at Ser 1179 was observed in MAs from Gla-null compared with WT mice (Ϫ21 Ϯ 0.67%, P ϭ 0.0343), consistent with the downregulation of eNOS activity (Fig. 6B) . In contrast to this modest difference, phosphorylation of eNOS at Thr 495 was markedly enhanced in MAs from aged Gla-null mice (Fig. 7A) . A 16-fold increase in phosphorylation of eNOS at Thr 495 was observed in MAs from 8-mo-old Gla-null compared with WT mice. The marked increase in Thr 495 phosphorylation is consistent with a suppression of eNOS activity (Fig. 7B) . Fig. 2 . ACh-mediated endothelium-dependent vasodilation in MAs from WT and Gla-knockout (Fabry) mice. All vessels (n ϭ 4 per group) were precontracted with 10 Ϫ5 M NE. A: percent relaxation in endothelium-intact MAs from 2-mo-old mice. B: percent relaxation in endothelium-intact MAs from 8-moold mice. Data are expressed as percent change in lumen diameter relative to baseline. **P Ͻ 0.01, ***P Ͻ 0.001 vs. WT (by 2-way ANOVA followed by Bonferroni's post hoc analysis). Fig. 1 . Age-dependent accumulation of globotriaosylceramide (Gb3) in mesenteric arteries (MAs) of wild-type (WT) and ␣-galactosidase A (Gla)-knockout (KO) mice. Neutral glycosphingolipids were extracted and purified from MAs of 2-and 9-mo-old WT and Gla-null (KO) mice. Neutral lipids, normalized to 50 nmol of total lipid phosphate, were spotted on highperformance thin-layer chromatography plates, and bands were visualized by charring with 8% cupric acetate in 8% phosphoric acid solution. A: representative separation of MA extracts from 3 separate mice per group. SM, sphingomyelin; Std, internal standard. B: combined densitometric analyses of Gb3 levels from all mice. Data are pooled from 3 individual experiments with 3 mice per group (n ϭ 9 per group). *P Ͻ 0.0001. C: deposition of Gb3 in Fabry mouse MAs progressively accumulated from 1 to 12 mo of age following lipid extraction. Each sample containing 40 nmol of total phospholipid phosphate was spotted onto a high-performance thin-layer chromatography plate. Each data point represents age (months) and average of triplicate samples (n ϭ 3).
Increased reactive nitrogen species in MAs from Gla-null mice.
Protein modification by nitration of tyrosine to 3-nitrotyrosine has been correlated with elevated oxidative stress and is specifically formed in the setting of eNOS uncoupling. The levels of protein-bound 3-nitrotyrosine in MAs from WT and Gla-null mice were measured using a specific antibody for protein-bound 3-nitrotyrosine. 3-Nitrotyrosine levels increased in mouse lines as a function of age (Fig. 8A) . However, protein-bound 3-nitrotyrosine content was significantly higher (ϳ4-fold) in MAs from Gla-null than WT mice at 2 and 8 mo of age (Fig. 8B) . These findings suggest that the Gla-null phenotype not only results in lower NO formation but also induces eNOS uncoupling and increased reactive nitrogen species formation in MAs.
DISCUSSION
Consistent with previous findings in other vascular beds (5, 22) , we observed an age-dependent accumulation of Gb3 in the MAs of Gla-null, but not WT, mice. We also measured a significant reduction in the vasodilatory capacity of MA in Gla-deficient mice. These data suggest that the endothelial dysfunction associated with Gb3 accumulation is widespread within the vasculature and includes the gastrointestinal microvessels. Similar to the previous findings in aortic rings (17) , an age-and endothelial cell-dependent dysfunction in the MA of Gla-null mice was observed, as manifest by a loss of ACh-stimulated vasodilation. The ability of SNP to restore the vasodilation was consistent with a primary defect in NO bioavailability. However, despite the profound nature of this defect, no spontaneous gastrointestinal phenotype was observed in Gla-null mice at any age. Surprisingly, the age of onset of the MA abnormality was earlier and the magnitude of the endothelial dysfunction appeared greater than in previously studied macrovessels, including the aorta and carotid arteries.
eNOS dysfunction may result from a decrease in NO bioavailability or enzyme uncoupling resulting in the formation of reactive nitrogen species. The active and functional form of eNOS is a dimer (19) . We therefore measured the dimerization and expression of eNOS in MAs from Gla-deficient and WT mice. In the older mice, total eNOS expression and eNOS Ϫ5 M NE. A: percent relaxation to SNP in endothelium-intact MAs from 2-mo-old mice. B: percent relaxation to SNP in endothelium-intact MAs from 8-mo-old mice. Data are expressed as percent change in lumen diameter relative to baseline. *P Ͻ 0.05, ***P Ͻ 0.001 vs. WT (by 2-way ANOVA followed by Bonferroni's post hoc analysis). dimerization were decreased significantly, suggesting that uncoupling of eNOS in the MA may, in part, contribute to the endothelial dysfunction. However, the measurement of eNOS monomers was also lower in Gla-deficient mice, and no difference in the eNOS monomer-to-homodimer ratio was evident between WT and Gla-deficient mice at 2 or 8 mo of age. In previous studies examining the effect of age on endothelial function in C57BL6/J mice, a significant increase in the eNOS monomer-to-dimer ratio in 24-vs. 3-mo-old MAs was observed with no significant difference in total eNOS protein levels (26) . Therefore, the reduction in eNOS protein and monomers in Gla-deficient mice does not appear to represent a simple acceleration of normal age-related changes. Rather, the changes likely represent a specific consequence of Gla deficiency, such as the accumulation of endothelial cell globo series glycosphingolipids.
NO production can lead to the formation of peroxynitrite (ONOO Ϫ ) in the setting of increased superoxide generation (9) . ONOO Ϫ is an oxidant and a nitrating agent that has been shown to induce cellular dysfunction and apoptosis (19) . Possibly, the increased levels of this oxidant during sustained periods of oxidative stress or resulting from eNOS uncoupling caused a decrease in the expression of functional eNOS. To explore the possibility that some of the abnormalities were mediated by ONOO Ϫ , the levels of 3-nitrotyrosine, an NOdependent nitrosative stress marker in the MA, was measured. 3-Nitrotyrosine was significantly elevated in MAs from Glaknockout mice at 2 mo of age, and the levels of 3-nitrotyrosine were further elevated in the older Gla-null mice, consistent with the early onset and a progressive increase in eNOS uncoupling in MAs from Fabry mice.
To further characterize the altered eNOS regulation in Gladeficient mice, posttranscriptional modifications to the eNOS protein were also evaluated. 1 and 2) . Monomeric eNOS was probed under denaturing conditions using 1% 2-mercaptoethanol (lanes 3 and 4) . ␤-Actin was also probed an internal loading control (bottom). MW, molecular weight. B: quantification of monomeric and dimeric eNOS in MAs from 8-mo-old WT and Gla-null mice (n ϭ 3 per group). Densitometric values are means Ϯ SE. *P Ͻ 0.05. (8, 11, 15) . Previous studies examining the function of Thr 495 and Ser 1179 mutated eNOS cells have suggested that the ratio of phosphorylated to dephosphorylated Thr 495 may act as an intrinsic switch for determining whether eNOS generates NO or superoxide anion (13) . Therefore, we measured phosphorylation of eNOS at Thr 495 in the MA to evaluate whether this site may be specifically altered in Gla-deficient mice.
eNOS phosphorylation at Thr 495 was highly increased in the older Gla-deficient mice compared with age-matched WT mice, suggesting that phosphorylation at Thr 495 may promote eNOS dysregulation in older Gla-null mice. Although we did not observe elevated phosphorylation at Thr 495 at 2 mo of age, we did observe evidence of elevated 3-nitrotyrosine at this younger age. These data are consistent with the interpretation that the modest early-onset phenotype of endothelial dysfunction is linked to NO uncoupling through a mechanism that is independent of Thr 495 phosphorylation. It is possible, therefore, that the more profound endothelial dysfunction at 8 mo is the result of the additional activation of the inhibitory eNOS Thr 495 site.
In addition to alterations in NO, endothelium-derived hyperpolarizing factor is also an ACh-mediated factor and is at least as important as NO in terms of endothelium-dependent vasodilation in the microvasculature (4, 21) . A recent study reported that Gb3 incubation partially inhibited ACh-mediated relaxation of mouse aortae (18) . In that study, a significant decrease in Ca 2ϩ -activated K ϩ (K Ca ) channel current and mRNA and protein expression was observed in aortic endothelial cells from Gla-deficient mice and WT mice treated with Gb3. Also, pharmacological blockade of the small-and intermediate-conductance K Ca channels has been demonstrated to increase superoxide formation and enhance eNOS phosphorylation at Thr 495 without changes in the total eNOS protein levels (10) . Thus Gb3 accumulation may lead to the earlier onset and profound endothelial dysfunction through direct effects on K Ca channel activity and an endothelial plasma membrane defect, which results in impaired or altered signaling of multiple endothelium-dependent relaxing factors, including NO and endothelium-derived hyperpolarizing factor.
In conclusion, this study provides the first evidence of microvascular endothelial dysfunction in a mouse model of Fabry disease. The accumulation of Gb3 and decrease in eNOS bioavailability, along with an increase in 3-nitrotyrosine in the MA, are consistent with the phenotype previously observed in macrovessels. In addition, the reciprocal dysregulation of 
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